EEF2K and melanoma: Additionally, doxorubicin has been shown to induce pyroptosis in melanoma by inhibiting eukaryotic elongation factor-2 kinase (eEF-2K), which not only enhances the anti-tumor effects but also suppresses autophagy (28).